Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionPublic Employees Retirement Association Of Colorado
Latest Disclosed Ownership10,796 shares
Latest Disclosed Value $ 321
Public Employees Retirement Association Of Colorado ownership in TVTX / Travere Therapeutics, Inc.

On May 14, 2026 - Public Employees Retirement Association Of Colorado filed a 13F-HR form disclosing ownership of 10,796 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $320,749 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,796 shares of Travere Therapeutics, Inc.. The current value of the position is $487,979 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0013
2026-02-13 2025-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0015
2025-11-13 2025-09-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0009
2025-08-11 2025-06-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0006
2025-05-12 2025-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0008
2025-02-14 2024-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0007
2024-11-14 2024-09-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0006
2024-08-12 2024-06-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0004
2024-05-15 2024-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0004
2024-02-13 2023-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0004
2023-11-14 2023-09-30 13F/A-1 TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0005
2023-11-14 2023-09-30 13F TRINSEO COM 89422G107 5,856 -4,940 0 0.0002
2023-08-09 2023-06-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0008
2023-05-08 2023-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 0.0013
2023-02-13 2022-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 0 -100.00 0.0012
2022-11-15 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 10,796 0 0.00 266 1.53 0.0015
2022-08-15 2022-06-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 262 -5.76 0.0014
2022-05-16 2022-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 278 -17.01 0.0013
2022-02-11 2021-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 335 27.86 0.0014
2021-11-15 2021-09-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 262 65.82 0.0012
2021-08-13 2021-06-30 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 158 -41.48 0.0007
2021-05-13 2021-03-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 270 -8.16 0.0013
2021-02-11 2020-12-31 13F TRAVERE THERA COM 89422G107 10,796 0 0.00 294 47.74 0.0014
2020-11-09 2020-09-30 13F RETROPHIN COM 761299106 10,796 0 0.00 199 -9.55 0.0011
2020-08-05 2020-06-30 13F RETROPHIN COM 761299106 10,796 0 0.00 220 39.24 0.0013
2020-05-27 2020-03-31 13F/A-1 RETROPHIN COM 761299106 10,796 0 0.00 158 3.27 0.0011
2020-05-01 2020-03-31 13F RETROPHIN COM 761299106 10,796 0 158 1,101.4073
2020-02-05 2019-12-31 13F RETROPHIN COM 761299106 10,796 0 0.00 153 22.40 0.0009
2019-11-05 2019-09-30 13F RETROPHIN COM 761299106 10,796 0 0.00 125 -42.40 0.0008
2019-07-31 2019-06-30 13F RETROPHIN COM 761299106 10,796 0 0.00 217 -11.07 0.0013
2019-04-30 2019-03-31 13F RETROPHIN COM 761299106 10,796 0 0.00 244 0.00 0.0016
2019-02-08 2018-12-31 13F RETROPHIN COM 761299106 10,796 0 0.00 244 -21.29 0.0018
2018-10-29 2018-09-30 13F RETROPHIN COM 761299106 10,796 0 0.00 310 5.44 0.0019
2018-08-02 2018-06-30 13F RETROPHIN COM 761299106 10,796 0 0.00 294 21.99 0.0019
2018-05-01 2018-03-31 13F RETROPHIN COM 761299106 10,796 0 0.00 241 6.17 0.0016
2018-02-02 2017-12-31 13F RETROPHIN COM 761299106 10,796 0 0.00 227 -15.61 0.0014
2017-10-30 2017-09-30 13F RETROPHIN COM 761299106 10,796 0 0.00 269 28.71 0.0019
2017-07-26 2017-06-30 13F RETROPHIN COM 761299106 10,796 0 0.00 209 5.03 0.0015
2017-05-02 2017-03-31 13F RETROPHIN COM 761299106 10,796 0 0.00 199 -2.45 0.0015
2017-02-02 2016-12-31 13F RETROPHIN COM 761299106 10,796 0 0.00 204 -15.70 0.0016
2016-11-01 2016-09-30 13F RETROPHIN COM 761299106 10,796 0 0.00 242 26.04 0.0020
2016-07-28 2016-06-30 13F RETROPHIN COM 761299106 10,796 0 0.00 192 30.61 0.0016
2016-04-29 2016-03-31 13F RETROPHIN COM 761299106 10,796 3,615 50.34 147 5.76 0.0012
2016-02-02 2015-12-31 13F RETROPHIN COM 761299106 7,181 0 0.00 139 -4.14 0.0012
2015-10-29 2015-09-30 13F RETROPHIN COM 761299106 7,181 0 0.00 145 -39.08 0.0013
2015-07-31 2015-06-30 13F RETROPHIN COM 761299106 7,181 7,181 238 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.